Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2010

Feb 19, 2010

29777_dirs_2010-02-18_382e8845-bbf1-4d3b-8125-bd77a66d12e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-02-16

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-16 Common shares without par value F 6460 $53.9300 Disposed 148882 Direct
2010-02-16 Common shares without par value S 1200 $54.511 Disposed 147682 Direct
2010-02-16 Common shares without par value S 2800 $54.50 Disposed 144882 Direct
2010-02-16 Common shares without par value S 1700 $54.51 Disposed 143182 Direct
2010-02-16 Common shares without par value S 8540 $54.49 Disposed 134642 Direct
2010-02-16 Common shares without par value S 100 $54.491 Disposed 134542 Direct
2010-02-16 Common shares without par value S 100 $54.4912 Disposed 134442 Direct
2010-02-16 Common shares without par value S 100 $54.4913 Disposed 134342 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 14644 Indirect
Common shares wihtout par value 295 Indirect
Common shares without par value 296 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2010.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughters.